Income Statement Genome & Company

Stocks

A314130

KR7314130006

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2026-07-03			5-day change	1st Jan Change
3,760.00 ^KRW	+1.21%		+5.17%	-45.35%

04-13	Genome & Company announced that it has received KRW 6.99999414 billion in funding	CI
04-02	Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding	CI

4588e2a91cf88506.L8SrggmGEENntYSDazCv8O4IFnPozG-PsmazStFw4OI.VZXGykjOcwIfgebuMkrsiIRJciy39RbO6A7CDekdsKBFm5rSZ9d4DwP7wQ

Published financial data: GENOME & COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	451M	14.08B	14.3B	27.74B	24.59B
Other Revenues, Total	-	-10	-	-10	-
Total Revenues	451M	14.08B	14.3B	27.74B	24.59B
Cost of Goods Sold, Total	77.01M	8.49B	10.23B	12.07B	11.18B
Gross Profit	374M	5.6B	4.06B	15.67B	13.41B
Selling General & Admin Expenses, Total	14.98B	19.66B	28.68B	22.02B	26.9B
R&D Expenses	21.26B	36.79B	25.67B	13.38B	11.95B
Depreciation & Amortization - (IS)	219M	1.89B	1.96B	1.61B	1.28B
Amortization of Goodwill and Intangible Assets - (IS)	-	4.76B	2.85B	2.86B	2.51B
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	36.46B	63.11B	59.16B	39.87B	42.64B
Operating Income	-36.09B	-57.51B	-55.09B	-24.2B	-29.23B
Interest Expense, Total	-54.92M	-175M	-1.74B	-3.54B	-4.72B
Interest And Investment Income	458M	851M	4.12B	3.78B	1.82B
Net Interest Expenses	403M	676M	2.38B	237M	-2.9B
Income (Loss) On Equity Invest.	-	-	-2.33B	-	-
Currency Exchange Gains (Loss)	-468M	-29.46M	-40.56M	-52.4M	236M
Other Non Operating Income (Expenses)	161M	-1.11B	3.25B	4.21B	31.56B
EBT, Excl. Unusual Items	-35.99B	-57.98B	-51.82B	-19.81B	-337M
Gain (Loss) On Sale Of Investments	-	-54.79M	46.44M	40.28M	-583M
Gain (Loss) On Sale Of Assets	-12.93M	688K	-77.11M	-79.51M	-76.89M
Asset Writedown	-	-	-	-8.37B	-3.1B
Other Unusual Items	-	-	-	-	-4.57B
EBT, Incl. Unusual Items	-36B	-58.03B	-51.85B	-28.21B	-8.67B
Income Tax Expense	-	-1.08B	-1.2B	-1.37B	-981M
Earnings From Continuing Operations	-36B	-56.95B	-50.65B	-26.85B	-7.69B
Net Income to Company	-36B	-56.95B	-50.65B	-26.85B	-7.69B
Minority Interest	1.89B	5.11B	3.19B	6.74B	1.26B
Net Income - (IS)	-34.12B	-51.84B	-47.47B	-20.11B	-6.43B
Net Income to Common Incl Extra Items	-34.12B	-51.84B	-47.47B	-20.11B	-6.43B
Net Income to Common Excl. Extra Items	-34.12B	-51.84B	-47.47B	-20.11B	-6.43B
Per Share Items
Net EPS - Basic	-1.27K	-1.84K	-1.68K	-660.2	-205.3
Basic EPS - Continuing Operations	-1.27K	-1.84K	-1.68K	-660.2	-205.3
Basic Weighted Average Shares Outstanding	26.88M	28.15M	28.24M	30.46M	31.31M
Net EPS - Diluted	-1.27K	-1.84K	-1.68K	-660.2	-205.3
Diluted EPS - Continuing Operations	-1.27K	-1.84K	-1.68K	-660.2	-205.3
Diluted Weighted Average Shares Outstanding	26.88M	28.15M	28.24M	30.46M	31.31M
Normalized Basic EPS	-766.57	-1.11K	-1.03K	-185.23	33.47
Normalized Diluted EPS	-766.57	-1.11K	-1.03K	-185.23	33.47
Supplemental Items
EBITDA	-33.5B	-48.05B	-46.82B	-16.75B	-22.56B
EBITA	-35.29B	-52.66B	-52.13B	-21.22B	-26.61B
EBIT	-36.09B	-57.51B	-55.09B	-24.2B	-29.23B
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	-	1.87	2.32	4.84	11.32
Normalized Net Income	-20.61B	-31.12B	-29.2B	-5.64B	1.05B
Supplemental Operating Expense Items
Advertising Expense	987M	1.5B	2.03B	3.8B	5.25B
Selling and Marketing Expenses	5.91B	4.2B	5.94B	8.86B	11.05B
General and Administrative Expenses	140M	690M	798M	687M	727M
Research And Development Expense From Footnotes	21.26B	36.79B	25.67B	13.38B	11.95B
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	3.36B	3.27B	9.34B	1.87B	2.16B
Total Stock-Based Compensation	3.36B	3.27B	9.34B	1.87B	2.16B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	36.05B	72.22B	56.36B	65.55B	15.6B
Short Term Investments	35.25B	28.21B	18.86B	8.23B	12.51B
Trading Asset Securities, Total	5.87B	6.28B	11.05B	7.15B	8.72B
Total Cash And Short Term Investments	77.16B	107B	86.27B	80.93B	36.83B
Accounts Receivable, Total	759M	1.96B	1.4B	2.06B	1.86B
Other Receivables	992M	864M	1.54B	383M	4.38B
Total Receivables	1.75B	2.82B	2.95B	2.44B	6.24B
Inventory	1.33B	2.24B	3.57B	5.77B	5.98B
Prepaid Expenses	1.1B	1.16B	1.15B	691M	1.11B
Other Current Assets, Total	433M	3.99B	3.11B	2.09B	2.13B
Total Current Assets	81.78B	117B	97.05B	91.93B	52.29B
Gross Property Plant And Equipment	25.69B	37.22B	52.7B	51.24B	46.25B
Accumulated Depreciation	-9.21B	-15.69B	-18.07B	-23.37B	-25.68B
Net Property Plant And Equipment	16.47B	21.53B	34.62B	27.87B	20.57B
Long-term Investments	-	-	-	-	-160
Goodwill	16.46B	16.46B	14.13B	14.13B	11.06B
Other Intangibles, Total	18.39B	13.92B	11.1B	8.26B	5.66B
Other Long-Term Assets, Total	4.12B	4.18B	5.15B	5.15B	55.43B
Total Assets	137B	173B	162B	147B	145B
Liabilities
Accounts Payable, Total	321M	205M	340M	481M	509M
Accrued Expenses, Total	1.71B	3.43B	2.72B	1.73B	1.37B
Short-term Borrowings	-	-	12B	18.4B	6.33B
Current Portion of Long-Term Debt	-	-	-	-	9B
Current Portion of Leases	1.58B	2.02B	1.05B	1.23B	1.32B
Current Income Taxes Payable	-	-	-	-	154K
Other Current Liabilities	6.21B	5.48B	12.12B	7.97B	4.11B
Total Current Liabilities	9.83B	11.14B	28.23B	29.81B	22.64B
Long-Term Debt	-	-	9.64B	9B	-
Long-Term Leases	5.24B	4.27B	3.76B	3.4B	2.33B
Deferred Tax Liability Non Current	6.83B	5.58B	4.41B	3.24B	2.18B
Other Non Current Liabilities	1.92B	1.46B	2.5B	2.82B	3.29B
Total Liabilities	23.82B	22.45B	48.54B	48.27B	30.43B
Preferred Stock Redeemable	-	-	-	-	-
Preferred Stock Non Redeemable	-	936M	720M	883M	4.69B
Total Preferred Equity	-	936M	720M	883M	4.69B
Common Stock, Total	7.03B	7.05B	7.36B	15.53B	17.32B
Additional Paid In Capital	257B	305B	305B	296B	307B
Retained Earnings	-185B	-237B	-285B	-305B	-311B
Comprehensive Income and Other	13.71B	21.78B	34.24B	40.2B	87.99B
Total Common Equity	92.73B	96.36B	61.71B	47.43B	101B
Minority Interest	20.67B	53.25B	51.09B	50.75B	8.8B
Total Equity	113B	151B	114B	99.06B	115B
Total Liabilities And Equity	137B	173B	162B	147B	145B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	28.13M	28.18M	29.45M	31.05M	34.65M
ECS Total Common Shares Outstanding	28.13M	28.18M	29.45M	31.05M	34.65M
Book Value / Share	3.3K	3.42K	2.1K	1.53K	2.92K
Tangible Book Value	57.89B	65.98B	36.47B	25.04B	84.37B
Tangible Book Value Per Share	2.06K	2.34K	1.24K	806.31	2.44K
Total Debt	6.83B	6.29B	26.45B	32.02B	18.97B
Net Debt	-70.34B	-100B	-59.82B	-48.91B	-17.86B
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	20.67B	53.25B	51.09B	50.75B	8.8B
Inventories - Raw Materials, Total	468M	331M	716M	650M	1B
Inventories - Work In Process, Total	185K	621M	976M	1.35B	1.07B
Inventories - Finished Goods, Total	858M	1.33B	2.21B	3.77B	3.91B
Inventories - Others	-740	-570	290	-490	400
Land - (BS)	-	10.59M	2.71B	2.7B	1.82B
Buildings, Total	-	-	9.22B	9.25B	6.21B
Machinery, Total	9.17B	14.66B	15.84B	18.06B	17.59B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-34.12B	-51.84B	-47.47B	-20.11B	-6.43B
Depreciation & Amortization - CF	1.8B	4.61B	5.31B	4.47B	4.05B
Amortization of Goodwill and Intangible Assets - (CF)	796M	4.85B	2.96B	2.97B	2.62B
Depreciation & Amortization, Total	2.59B	9.46B	8.27B	7.45B	6.67B
(Gain) Loss From Sale Of Asset	12.93M	-688K	77.11M	79.51M	76.89M
(Gain) Loss on Sale of Investments - (CF)	-	54.79M	-46.44M	-40.28M	583M
Asset Writedown & Restructuring Costs	-	-	2.33B	8.37B	3.1B
Stock-Based Compensation (CF)	5.57B	6.08B	12.07B	2.34B	3.15B
Provision and Write-off of Bad Debts	-	-12.92M	-	-	-
Other Operating Activities, Total	-1.66B	-5.03B	-4.65B	-8.96B	-23.43B
Change In Accounts Receivable	11.95M	-1.14B	1.13B	-459M	153M
Change In Inventories	-154M	-886M	-1.69B	-1.9B	-309M
Change In Accounts Payable	14.8M	-140M	133M	88.24M	40.29M
Change in Other Net Operating Assets	1.57B	-92.71M	-2.37B	-3.18B	-2B
Cash from Operations	-26.16B	-43.55B	-32.22B	-16.33B	-18.39B
Capital Expenditure	-2.88B	-6.85B	-18.85B	-3.97B	-285M
Sale of Property, Plant, and Equipment	500K	960K	-	-	-
Cash Acquisitions	-26.72B	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-505M	-427M	-189M	-216M	-151M
Investment in Marketable and Equity Securities, Total	-29.61B	993M	4.74B	15.85B	-7.53B
Other Investing Activities, Total	-100M	-99.49M	-1.13B	-113M	471M
Cash from Investing	-59.81B	-6.38B	-15.43B	11.55B	-7.49B
Long-Term Debt Issued, Total	-	-	32.51B	5.83B	142M
Total Debt Issued	-	-	32.51B	5.83B	142M
Long-Term Debt Repaid, Total	-820M	-1.65B	-2.02B	-568M	-20.91B
Total Debt Repaid	-820M	-1.65B	-2.02B	-568M	-20.91B
Issuance of Common Stock	1.25B	127M	81.49M	33.84M	-
Repurchase of Common Stock	-	-	-	-	-54.16B
Issuance of Preferred Stock	17.13B	80.03B	-	-	25.73B
Other Financing Activities, Total	57.69M	35.61M	-	-49.78M	27.02B
Cash from Financing	17.62B	78.55B	30.57B	5.25B	-22.17B
Foreign Exchange Rate Adjustments	453M	7.55B	1.23B	8.73B	-1.9B
Miscellaneous Cash Flow Adjustments	-100	30	-340	460	-1.07K
Net Change in Cash	-67.9B	36.17B	-15.86B	9.19B	-49.95B
Supplemental Items
Cash Interest Paid	52.71M	171M	311M	587M	597M
Cash Income Tax Paid (Refund)	10.84M	54.31M	92.92M	70.95M	41.21M
Levered Free Cash Flow	-17.13B	-35.32B	-31.46B	-17.43B	-21.48B
Unlevered Free Cash Flow	-17.09B	-35.21B	-30.37B	-15.22B	-18.53B
Change In Net Working Capital	-2.89B	4.72B	-5.49B	5.23B	8.65B
Net Debt Issued / Repaid	-820M	-1.65B	30.49B	5.26B	-20.77B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-17.48	-23.17	-20.55	-9.78	-12.5
Return on Total Capital	-19.03	-25.95	-23.2	-11.16	-13.81
Return On Equity %	-31.52	-43.15	-38.36	-25.26	-7.2
Return on Common Equity	-33.42	-54.83	-60.06	-36.86	-8.66
Margin Analysis
Gross Profit Margin %	82.93	39.74	28.43	56.48	54.53
SG&A Margin	3.32K	139.61	200.59	79.38	109.43
EBITDA Margin %	-7.42K	-341.16	-327.5	-60.38	-91.77
EBITA Margin %	-7.82K	-373.9	-364.64	-76.5	-108.23
EBIT Margin %	-8K	-408.34	-385.37	-87.22	-118.9
Income From Continuing Operations Margin %	-7.98K	-404.34	-354.31	-96.77	-31.26
Net Income Margin %	-7.56K	-368.05	-332.02	-72.49	-26.14
Net Avail. For Common Margin %	-7.56K	-368.05	-332.02	-72.49	-26.14
Normalized Net Income Margin	-4.57K	-220.98	-204.27	-20.34	4.26
Levered Free Cash Flow Margin	-3.8K	-250.79	-220.04	-62.83	-87.37
Unlevered Free Cash Flow Margin	-3.79K	-250.01	-212.44	-54.86	-75.37
Asset Turnover
Asset Turnover	0	0.09	0.09	0.18	0.17
Fixed Assets Turnover	0.04	0.74	0.51	0.89	1.02
Receivables Turnover (Average Receivables)	-	10.37	8.51	16.03	12.56
Inventory Turnover (Average Inventory)	-	4.76	3.52	2.59	1.9
Short Term Liquidity
Current Ratio	8.32	10.49	3.44	3.08	2.31
Quick Ratio	8.03	9.83	3.16	2.8	1.9
Operating Cash Flow to Current Liabilities	-2.66	-3.91	-1.14	-0.55	-0.81
Days Sales Outstanding (Average Receivables)	-	35.19	42.87	22.83	29.06
Days Outstanding Inventory (Average Inventory)	-	76.65	103.55	141.54	191.8
Average Days Payable Outstanding	-	10.23	8.61	10.53	15.87
Cash Conversion Cycle (Average Days)	-	101.62	137.81	153.84	204.99
Long Term Solvency
Total Debt/Equity	6.02	4.18	23.3	32.33	16.55
Total Debt / Total Capital	5.68	4.01	18.9	24.43	14.2
LT Debt/Equity	4.62	2.83	11.81	12.51	2.03
Long-Term Debt / Total Capital	4.36	2.72	9.57	9.46	1.74
Total Liabilities / Total Assets	17.36	12.98	29.95	32.76	20.99
EBIT / Interest Expense	-657.05	-328.65	-31.69	-6.83	-6.19
EBITDA / Interest Expense	-609.86	-274.58	-26.93	-4.73	-4.78
(EBITDA - Capex) / Interest Expense	-662.22	-313.72	-37.78	-5.85	-4.84
Total Debt / EBITDA	-0.2	-0.13	-0.56	-1.91	-0.84
Net Debt / EBITDA	2.1	2.09	1.28	2.92	0.79
Total Debt / (EBITDA - Capex)	-0.19	-0.11	-0.4	-1.55	-0.83
Net Debt / (EBITDA - Capex)	1.93	1.83	0.91	2.36	0.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	199.67	3.02K	1.5	94.07	-11.38
Gross Profit, 1 Yr. Growth %	148.53	1.4K	-27.4	285.59	-14.45
EBITDA, 1 Yr. Growth %	33.11	43.45	-2.56	-64.22	34.69
EBITA, 1 Yr. Growth %	34.54	49.22	-1.01	-59.28	25.37
EBIT, 1 Yr. Growth %	35.52	59.37	-4.21	-56.08	20.81
Earnings From Cont. Operations, 1 Yr. Growth %	15.45	58.18	-11.06	-46.99	-71.37
Net Income, 1 Yr. Growth %	11.01	51.94	-8.43	-57.63	-68.04
Normalized Net Income, 1 Yr. Growth %	8.58	51.04	-6.18	-79.67	-118.57
Diluted EPS Before Extra, 1 Yr. Growth %	-20.48	45.1	-8.72	-60.72	-68.89
Accounts Receivable, 1 Yr. Growth %	-	157.71	-28.36	46.93	-9.93
Inventory, 1 Yr. Growth %	-	68.64	59.45	61.75	3.61
Net Property, Plant and Equip., 1 Yr. Growth %	285.72	30.66	60.85	-19.51	-26.2
Total Assets, 1 Yr. Growth %	13.51	26.08	-6.32	-9.09	-1.58
Tangible Book Value, 1 Yr. Growth %	-45.68	13.98	-44.72	-31.35	236.95
Common Equity, 1 Yr. Growth %	-16.78	3.91	-35.96	-23.14	113.13
Cash From Operations, 1 Yr. Growth %	44.07	66.48	-26.01	-49.32	12.59
Capital Expenditures, 1 Yr. Growth %	91.12	138.21	175.27	-78.94	-92.83
Levered Free Cash Flow, 1 Yr. Growth %	-77.68	106.21	-10.94	-44.55	23.22
Unlevered Free Cash Flow, 1 Yr. Growth %	-77.5	105.99	-13.75	-49.86	21.75
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	213.77	867.13	462.86	40.35	31.14
Gross Profit, 2 Yr. CAGR %	259.47	509.71	229.53	67.31	81.63
EBITDA, 2 Yr. CAGR %	58.99	38.18	18.23	-40.96	-30.58
EBITA, 2 Yr. CAGR %	59.87	41.69	21.54	-36.51	-28.55
EBIT, 2 Yr. CAGR %	61.58	46.96	23.56	-35.13	-27.15
Earnings From Cont. Operations, 2 Yr. CAGR %	-34.79	35.13	18.61	-31.34	-61.04
Net Income, 2 Yr. CAGR %	-36.52	29.88	17.95	-37.71	-63.2
Normalized Net Income, 2 Yr. CAGR %	-37.6	28.06	19.04	-57.42	-80.57
Diluted EPS Before Extra, 2 Yr. CAGR %	-50.98	7.42	15.09	-40.12	-65.05
Accounts Receivable, 2 Yr. CAGR %	-	-	35.88	2.6	15.04
Inventory, 2 Yr. CAGR %	-	-	63.98	60.59	29.45
Net Property, Plant and Equip., 2 Yr. CAGR %	137.28	124.5	44.97	13.79	-22.93
Total Assets, 2 Yr. CAGR %	97.48	19.63	8.68	-7.71	-5.41
Tangible Book Value, 2 Yr. CAGR %	20.29	-21.31	-20.62	-38.4	52.09
Common Equity, 2 Yr. CAGR %	52.88	-7.01	-18.43	-29.84	27.99
Cash From Operations, 2 Yr. CAGR %	61.35	54.87	10.99	-38.76	-24.46
Capital Expenditures, 2 Yr. CAGR %	104.5	113.37	156.07	-23.87	-87.71
Levered Free Cash Flow, 2 Yr. CAGR %	-	-32.15	35.52	-29.75	-17.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-31.91	33.29	-34.26	-21.87
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	574.82	356.19	294.69	20.41
Gross Profit, 3 Yr. CAGR %	-	478.18	199.96	247.25	33.79
EBITDA, 3 Yr. CAGR %	-	53.63	22.99	-20.62	-22.27
EBITA, 3 Yr. CAGR %	-	56.24	25.73	-15.59	-20.35
EBIT, 3 Yr. CAGR %	-	60.84	27.42	-12.47	-20.19
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-12.38	17.55	-9.32	-48.7
Net Income, 3 Yr. CAGR %	-	-15.09	15.59	-16.15	-50.13
Normalized Net Income, 3 Yr. CAGR %	-	-16.21	15.45	-35.06	-67.71
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-29.62	1.74	-19.57	-51.87
Accounts Receivable, 3 Yr. CAGR %	-	-	-	39.47	-1.76
Inventory, 3 Yr. CAGR %	-	-	-	63.23	38.77
Net Property, Plant and Equip., 3 Yr. CAGR %	-	94.49	100.88	19.15	-1.51
Total Assets, 3 Yr. CAGR %	-	70.04	10.26	2.4	-5.71
Tangible Book Value, 3 Yr. CAGR %	-	18.15	-30.05	-24.37	8.54
Common Equity, 3 Yr. CAGR %	-	34.42	-17.88	-20.03	1.61
Cash From Operations, 3 Yr. CAGR %	-	63.04	21.07	-14.53	-24.98
Capital Expenditures, 3 Yr. CAGR %	-	115.17	132.28	11.35	-65.36
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-25.71	0.59	-15.28
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-26.33	-3.8	-19.26
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	260.08	177.07
Gross Profit, 5 Yr. CAGR %	-	-	-	252.08	145.42
EBITDA, 5 Yr. CAGR %	-	-	-	4.8	-2.16
EBITA, 5 Yr. CAGR %	-	-	-	8.98	0.29
EBIT, 5 Yr. CAGR %	-	-	-	11.85	1.88
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-20.52	-24.43
Net Income, 5 Yr. CAGR %	-	-	-	-24.98	-26.87
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-36.09	-43.97
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-34.02	-33.65
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	56.95	36.94
Total Assets, 5 Yr. CAGR %	-	-	-	33.16	3.71
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-8.95	-4.56
Common Equity, 5 Yr. CAGR %	-	-	-	3.63	-1.93
Cash From Operations, 5 Yr. CAGR %	-	-	-	10.2	0.25
Capital Expenditures, 5 Yr. CAGR %	-	-	-	42	-28.32
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-22.48
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-24.58